BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1170 related articles for article (PubMed ID: 17629825)

  • 1. Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Kowalczyk J; Lenarczyk R; Kowalski O; Swiatkowski A; Stabryła-Deska J; Kurek T; Honisz G; Kukulski T; Gasior M; Kalarus Z
    Kardiol Pol; 2007 Jun; 65(6):635-43; discussion 644. PubMed ID: 17629825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different types of renal dysfunction in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Kowalczyk J; Lenarczyk R; Kowalski O; Sredniawa B; Musialik-Lydka A; Gasior M; Polonski L; Zembala M; Gumprecht J; Kalarus Z
    J Interv Cardiol; 2007 Apr; 20(2):143-52. PubMed ID: 17391223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of anemia in high-risk groups of patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Kurek T; Lenarczyk R; Kowalczyk J; Swiatkowski A; Kowalski O; Stabryła-Deska J; Honisz G; Lekston A; Kalarus Z; Kukulski T
    Am J Cardiol; 2010 Mar; 105(5):611-8. PubMed ID: 20185005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated admission serum creatinine predicts poor myocardial blood flow and one-year mortality in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
    Zhao L; Wang L; Zhang Y
    J Invasive Cardiol; 2009 Oct; 21(10):493-8. PubMed ID: 19805833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction.
    Marenzi G; Lauri G; Assanelli E; Campodonico J; De Metrio M; Marana I; Grazi M; Veglia F; Bartorelli AL
    J Am Coll Cardiol; 2004 Nov; 44(9):1780-5. PubMed ID: 15519007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary intervention.
    Ishii H; Ichimiya S; Kanashiro M; Aoyama T; Ogawa Y; Murakami R; Amano T; Naruse K; Matsubara T; Murohara T
    Clin Ther; 2006 Nov; 28(11):1812-9. PubMed ID: 17213001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of admission creatinine level on clinical outcomes of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention with drug-eluting stent implantation.
    Zhang Q; Zhang RY; Shen J; Zhang JS; Hu J; Yang ZK; Zhang X; Zheng AF; Shen WF
    Chin Med J (Engl); 2008 Dec; 121(23):2379-83. PubMed ID: 19102952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis in diabetic patients with acute myocardial infarction treated invasively is related to renal function.
    Kowalczyk J; Lenarczyk R; Strojek K; Zielinska T; Gumprecht J; Sedkowska A; Kukulski T; Swierad M; Kowalski O; Sredniawa B; Polonski L; Zembala M; Kalarus Z
    Med Sci Monit; 2010 Feb; 16(2):CR67-74. PubMed ID: 20110917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome.
    Senoo T; Motohiro M; Kamihata H; Yamamoto S; Isono T; Manabe K; Sakuma T; Yoshida S; Sutani Y; Iwasaka T
    Am J Cardiol; 2010 Mar; 105(5):624-8. PubMed ID: 20185007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between blood glucose on admission and prognosis in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Gasior M; Stasik-Pres G; Pres D; Lech P; Gierlotka M; Lekston A; Hawranek M; Tajstra M; Kalarus Z; Poloński L
    Kardiol Pol; 2007 Sep; 65(9):1031-8; discussion 1039-40. PubMed ID: 17975750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of advanced chronic kidney disease on in-hospital mortality following percutaneous coronary intervention for acute myocardial infarction.
    Vasu S; Gruberg L; Brown DL
    Catheter Cardiovasc Interv; 2007 Nov; 70(5):701-5. PubMed ID: 17932900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention.
    Nikolsky E; Mehran R; Turcot D; Aymong ED; Mintz GS; Lasic Z; Lansky AJ; Tsounias E; Moses JW; Stone GW; Leon MB; Dangas GD
    Am J Cardiol; 2004 Aug; 94(3):300-5. PubMed ID: 15276092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does glucose level at hospital discharge predict one-year mortality in patients with diabetes mellitus treated with percutaneous coronary intervention for ST-segment elevation myocardial infarction?
    Gasior M; Pres D; Stasik-Pres G; Lech P; Gierlotka M; Lekston A; Hawranek M; Tajstra M; Kalarus Z; Poloński L
    Kardiol Pol; 2008 Jan; 66(1):1-8; discussion 9-11. PubMed ID: 18266182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of complete revascularization in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Kalarus Z; Lenarczyk R; Kowalczyk J; Kowalski O; Gasior M; Was T; Zebik T; Krupa H; Chodór P; Poloński L; Zembala M
    Am Heart J; 2007 Feb; 153(2):304-12. PubMed ID: 17239694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-type natriuretic peptide for prevention of contrast-induced nephropathy in patients with heart failure undergoing primary percutaneous coronary intervention.
    Zhang J; Fu X; Jia X; Fan X; Gu X; Li S; Wu W; Fan W; Su J; Hao G; Jiang Y; Xue L
    Acta Radiol; 2010 Jul; 51(6):641-8. PubMed ID: 20438292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of kidney function in patients with ST-elevation and non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention.
    Seyfarth M; Kastrati A; Mann JF; Ndrepepa G; Byrne RA; Schulz S; Mehilli J; Schömig A
    Am J Kidney Dis; 2009 Nov; 54(5):830-9. PubMed ID: 19592145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined impact of age and estimated glomerular filtration rate on in-hospital mortality after percutaneous coronary intervention for acute myocardial infarction (from the American College of Cardiology National Cardiovascular Data Registry).
    Cardarelli F; Bellasi A; Ou FS; Shaw LJ; Veledar E; Roe MT; Morris DC; Peterson ED; Klein LW; Raggi P
    Am J Cardiol; 2009 Mar; 103(6):766-71. PubMed ID: 19268729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention.
    Nyman U; Björk J; Aspelin P; Marenzi G
    Acta Radiol; 2008 Jul; 49(6):658-67. PubMed ID: 18568558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction.
    Timmer JR; van der Horst IC; Ottervanger JP; Henriques JP; Hoorntje JC; de Boer MJ; Suryapranata H; Zijlstra F;
    Am Heart J; 2004 Sep; 148(3):399-404. PubMed ID: 15389225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention.
    Iakovou I; Dangas G; Mehran R; Lansky AJ; Ashby DT; Fahy M; Mintz GS; Kent KM; Pichard AD; Satler LF; Stone GW; Leon MB
    J Invasive Cardiol; 2003 Jan; 15(1):18-22. PubMed ID: 12499523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.